Success
You’re all set!

Have questions or want to explore how Posit can support your work?
Join the discussion
While you’re here, keep the momentum going by checking out our latest blogs on life sciences.

Register for R/Pharma at posit::conf(2025)
Join us starting on September 15 at posit::conf(2025) to discuss the future of open-source drug development with experts from Genentech, GSK, JnJ, Novartis, Roche, Posit, and many more!

Johnson & Johnson x Posit Live Event March 2025 Q&A
A team from J&J shares how they navigated the challenges of open-source adoption while cultivating a programmer-friendly environment that promotes sharing and continuous learning.

Collaborating Across Pharma: Open Source Highlights from the PHUSE US Connect 2024 Keynote
At PHUSE US Connect 2024, Michael Rimler (GSK) and Ross Farrugia (Roche) called for open-source collaboration in pharma to drive innovation and improve patient outcomes.

Enabling the pharmaceutical programming community to develop ADaM datasets in R: Four Perspectives From the Maintainers
Join the discussion